MTANZ board member Aisling Weir explores the history and complexities of medical device regulation in New Zealand. She discusses the challenges and opportunities within the evolving landscape of medical technology and how new legislation - the Medical Products Bill - aims to address these issues. Also, the difficulty of regulating AI in relation to medical devices and what New Zealand could learn from how international regulatory agencies are approaching this.
All content for eHealthTALK NZ is the property of Rebecca McBeth and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
MTANZ board member Aisling Weir explores the history and complexities of medical device regulation in New Zealand. She discusses the challenges and opportunities within the evolving landscape of medical technology and how new legislation - the Medical Products Bill - aims to address these issues. Also, the difficulty of regulating AI in relation to medical devices and what New Zealand could learn from how international regulatory agencies are approaching this.
Strengths, not deficits: A blind low vision perspective on working in healthcare
eHealthTALK NZ
25 minutes
3 weeks ago
Strengths, not deficits: A blind low vision perspective on working in healthcare
In this episode Sally Britnell, a disability advocate and senior lecturer, discusses the challenges and barriers faced by disabled people in the healthcare sector. Sally shares her personal journey of working in health and the importance of representation in the health workforce. She reflects on the current state of inclusivity, experiences of discrimination, and explores the need for universal design in workplaces. Also, the role of digital tools in enhancing accessibility, the support emplo...
eHealthTALK NZ
MTANZ board member Aisling Weir explores the history and complexities of medical device regulation in New Zealand. She discusses the challenges and opportunities within the evolving landscape of medical technology and how new legislation - the Medical Products Bill - aims to address these issues. Also, the difficulty of regulating AI in relation to medical devices and what New Zealand could learn from how international regulatory agencies are approaching this.
